Stellar science ..Canada's best "homegrown"...a must listen!Sure it is fun to observe "compensated peeps" work a social media feed 24/7 in order to "protect the kindling", but let us not lose focus on the potential here and dedicated journey of people like Dr. Paul Walker our former CEO ( current director ) and pioneer in the area of sepsis and specifically "Endotoxemic Septic Shock".
Listen closely to the first three minutes of this link, it is brilliant and describes a condition that our knew CMO ( American legend Dr. J Kellum ) now seems focussed upon ( as per his recent 55 minute presentation to the Sepsis Alliance )
I am not a "game player" like those asked to populate this social media feed. I am a serious private invester with a keen interest in this company. LISTEN closely ( link at bottom ), we have a solution for a condition to which no other viable solution exists. Sure we may have "mixed up" our phase 2 and phase 3 a little ( you have to break a few eggs to make an omelette ), BUT the phase 3B is likely right on track due to "lessons learned"...soon we will know, as INSIDERS DO, it is Open Label and we are approaching, if not beyond, 30 patients. Sharing is now essential and LIKELY why NOT a stitch of insider activity has taken place since the 42.5 cent US deal was done ( July 21/21 ). At 31 cents CAD, it is "no harm no foul"..brilliant...as is our science - IMHO and apparently the FDA agrees as the current phase 3B TIGRIS uses a 2 to 1 ratio in favor of our medical device ( PMX ) and the "state-of-the-art" theranostic packaging ( PMX - FDA pending, SAMI - FDA approved, EAA - FDA approved )
Please listen to the first 3 minutes and entire 14 minutes if you wish and feel free to ask questions. I am here as a common shareholder to support others of the same. This forum is designed for ethical, factual and supportive discussion..something I take seriously....please do your own homework and be informed like a few select posters here are:
Our CMO, now residing in the TOP .0029% of sepsis experts has delared that >70% of sepsis patients with high endotoxin activity have "NEGATIVE BLOOD CULTURES"...
Listen closely to the important interview below...even just the first 3 minutes.
https://www.massdevice.com/leading-battle-sepsis-massdevice-podcast-spectral-medical-ceo-paul-walker/